Clinical Trial VICCPED1258
Title
Mutations in DICER1 and Related MicroRNA Processing Genes in Dysplasias, Dysontogenic Diseases, Tumors and Other Conditions
Principal Investigator(s)
Details
- Protocol No. VICCPED1258
- Open Date: 09/06/2012
- Staging: NA
- Age Group: Both Child and Adult
- Scope: International
- Objective: The general hypothesis we plan to test is that germ-line and somatic mutations in DICER1 are associated with a greater range of benign and malignant conditions than is currently ascribed to dysfunction of DICER1.
- Disease Sites: Pediatric Solid Tumors
- Therapies: None Specified
- Drugs: None Specified
- Participating Institutions: Vanderbilt University
- Secondary Protocol No: Not Specified
Description
None Provided.
Eligibility
Not provided. Please call for more information.
Learn More
- Call toll-free number: 1-800-811-8480
- Use our Online self–referral form
- Print this page for your doctor
You do not have JavaScript enabled. This site works better with JavaScript turned on.
